Scotts Miracle Gro Analyst Price Targets - Benzinga

The Scotts Miracle Gro Co

SMGNYSE

Trade with Public

Trade with Public

$61.87

2.213.7%

마지막 업데이트: Oct 29, 4:42 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Scotts Miracle Gro Analyst Price Targets

Wall Street analyst price targets and consensus rating for Scotts Miracle Gro (SMG).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

5Buy

2Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$71Upside to Avg. PT+14.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	UBS	Peter Grom	Upgrade	Neutral→Buy	$78→$70
Oct 5, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$77→$60
Sep 29, 2026	Stifel	W. Andrew Carter	PT Cut	Buy	$76→$75
Aug 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$75→$76
Jul 30, 2026	UBS	Peter Grom	PT Raise	Neutral	$70→$78
Jul 30, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$74→$77
Jul 16, 2026	UBS	Peter Grom	PT Raise	Neutral	$63→$70
Jul 8, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$72→$74
Jun 8, 2026	Stifel	W. Andrew Carter	PT Cut	Buy	$76→$75
Apr 8, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$72
Mar 26, 2026	JP Morgan	Jeffrey Zekauskas	Downgrade	Overweight→Neutral	$67
Mar 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$70→$79
Jan 29, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$67→$70
Jan 14, 2026	UBS	Peter Grom	PT Raise	Neutral	$61→$66
Nov 6, 2025	UBS	Peter Grom	PT Cut	Neutral	$62→$61
Nov 6, 2025	Stifel	W. Andrew Carter	Upgrade	Hold→Buy	$70
Nov 5, 2025	Jefferies	Jonathan Matuszewski	PT Raise	Buy	$71→$74
Oct 2, 2025	UBS	Peter Grom	PT Cut	Neutral	$68→$62
Sep 25, 2025	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$67
Aug 4, 2025	Stifel	W. Andrew Carter	PT Cut	Hold	$71→$70

Analyst Ratings News

PRO
UBS Upgrades Scotts Miracle Gro to Buy, Lowers Price Target to $70

UBS analyst Peter Grom upgrades Scotts Miracle Gro (NYSE:SMG) from Neutral to Buy and lowers the price target from $78 to $70.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $60

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Lowers Price Target to $75

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and lowers the price target from $76 to $75.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Raises Price Target to $76

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and raises the price target from $75 to $76.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $78

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $70 to $78.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $77

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $74 to $77.

Benzinga Newsdesk